Search results for "Inflammation."

showing 10 items of 2627 documents

Telomeres and telomerase in risk assessment of cardiovascular diseases

2020

Telomeres are repetitive nucleoprotein structures located at the ends of chromosomes. Reduction in the number of repetitions causes cell senescence. Cells with high proliferative potential age with each replication cycle. Post- mitotic cells (e.g. cardiovascular cells) have a different aging mechanism. During the aging of cardiovascular system cells, permanent DNA damage occurs in the telomeric regions caused by mitochondrial dysfunction, which is a phenomenon independent of cell proliferation and telomere length. Mitochondrial dysfunction is accompanied by increased production of reactive oxygen species and development of inflammation. This phe-nomenon in the cells of blood vessels can lea…

0301 basic medicineSenescenceTelomeraseDNA damageCellInflammationBiologySenescence03 medical and health sciences0302 clinical medicineHistone H2AmedicineAnimalsHumansTelomeraseCellular SenescenceTelomere ShorteningCell growthCell BiologyTelomere030104 developmental biologymedicine.anatomical_structureTelomeresCardiovascular diseases030220 oncology & carcinogenesisCancer researchmedicine.symptomDNA DamageExperimental Cell Research
researchProduct

Ageing: from inflammation to cancer.

2018

Abstract Ageing is the major risk factor for cancer development. Hallmark of the ageing process is represented by inflammaging, which is a chronic and systemic low-grade inflammatory process. Inflammation is also a hallmark of cancer and is widely recognized to influence all cancer stages from cell transformation to metastasis. Therefore, inflammaging may represent the biological phenomena able to couple ageing process with cancer development. Here we review the molecular and cellular pathway involved in age-related chronic inflammation along with its potential triggers and their connection with cancer development.

0301 basic medicineSenescencelcsh:Immunologic diseases. AllergyAgingCellImmunologyAgeing; Cancer; DAMPs; Inflammation; MiRna; Microbiota; Obesity; SenescenceInflammationReviewlcsh:GeriatricsSenescenceMetastasis03 medical and health sciencesmicroRNAMedicineDAMPObesityCancerSettore MED/04 - Patologia GeneraleInflammationDAMPsbusiness.industryAgeing; Cancer; DAMPs; Inflammation; Microbiota; MiRna; Obesity; Senescence; Immunology; AgingMicrobiotaCancermedicine.diseaselcsh:RC952-954.6Ageing030104 developmental biologymedicine.anatomical_structureAgeingCancer researchSettore MED/26 - NeurologiaCancer developmentmedicine.symptombusinesslcsh:RC581-607MiRna
researchProduct

From Genesis to Revelation: The Role of Inflammatory Mediators in Chronic Respiratory Diseases and their Control by Nucleic Acid-based Drugs.

2015

Asthma, chronic obstructive pulmonary disease, cystic fibrosis, and idiopathic pulmonary fibrosis, are among the most common chronic diseases and their prevalence is increasing. Each of these diseases is characterized by the secretion of cytokines and pro-inflammatory molecules which are thought to play a critical role in their pathogenesis. Moreover, immune cells, particularly neutrophils, macrophages and dendritic cells as well structural cells such as epithelial and airway smooth muscle cells are also involved in the pathogenic cycle of these diseases. There is a pressing need for the development of new therapies for these pulmonary diseases, particularly as no existing treatment has bee…

0301 basic medicineSmall interfering RNARespiratory diseasessiRNA deliveryHMGB1 (high-mobility group box 1)medicine.medical_treatmentGenetic enhancementOligonucleotidesPharmaceutical Science02 engineering and technologyBiologySmall InterferingPathogenesis03 medical and health sciencesIdiopathic pulmonary fibrosisImmune systemRNA interferenceNucleic AcidsmedicineAnimalsHumansAntisenseHMGB1 ProteinRNA Small InterferingCatalyticLungNABDs deliveryDNADNA CatalyticGenetic TherapyOligonucleotides Antisense021001 nanoscience & nanotechnologymedicine.diseaseRespiration Disorders030104 developmental biologyCytokinemedicine.anatomical_structureImmunologyChronic DiseaseRNAInflammation Mediators0210 nano-technologyHMGB1 (high-mobility group box 1); Inflammation mediators; NABDs delivery; Respiratory diseases; siRNA delivery; Animals; Chronic Disease; DNA Catalytic; HMGB1 Protein; Humans; Inflammation Mediators; Nucleic Acids; Oligonucleotides Antisense; RNA Small Interfering; Respiration Disorders; Genetic TherapyCurrent drug delivery
researchProduct

The role of the gastrointestinal tract in the pathogenesis of rheumatic diseases

2016

Dysregulation of the intestinal epithelial barrier in genetically susceptible individuals may lead to both intestinal and extraintestinal autoimmune disorders. There is emerging literature on the role of microbiota changes in the pathogenesis of systemic rheumatic diseases such as rheumatoid arthritis, spondyloarthropathies, and connective tissue diseases. Although the role of the gastrointestinal tract in the pathogenesis of spondyloartropathies is well defined and many studies underline the importance of gastrointestinal inflammation in modulating local and systemic inflammation, the data are inconclusive regarding the effect of dysbiosis on rheumatoid arthritis and connective tissue dise…

0301 basic medicineSpondyloarthropathyConnective tissueSystemic inflammationPathogenesis03 medical and health sciences0302 clinical medicineRheumatologyRheumatic DiseasesmedicineHumans030203 arthritis & rheumatologyEpithelial barrierGastrointestinal tractbusiness.industryRheumatoid arthritis Spondyloarthropathy Connective tissue diseases Gastrointestinal tract Dysbiosismedicine.diseaseGastrointestinal MicrobiomeSettore MED/16 - Reumatologia030104 developmental biologymedicine.anatomical_structureRheumatoid arthritisImmunologyDysbiosismedicine.symptombusinessDysbiosis
researchProduct

Stress/inflammation and pai-1 as stellar processes in the aging and associated pathologies

2018

0301 basic medicineStress (mechanics)03 medical and health sciences030104 developmental biologybusiness.industryImmunologyMedicineInflammationmedicine.symptombusinessIntegrative Molecular Medicine
researchProduct

2021

Background: Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease and patients are under an increased risk for cardiovascular (CV) events and mortality. The increased CV risk for patients with SLE seems to be caused by a premature and accelerated atherosclerosis, attributable to lupus-specific risk factors (i.e., increased systemic inflammation, altered immune status), apart from traditional CV risk factors. To date, there is no established experimental model to explore the pathogenesis of this increased CV risk in SLE patients. Methods: Here we investigated whether MRL-Faslpr mice, which develop an SLE-like phenotype, may serve as a model to study lupus-mediated v…

0301 basic medicineSystemic inflammationCatalysisInorganic ChemistryPathogenesis03 medical and health sciences0302 clinical medicineimmune system diseasesmedicinePhysical and Theoretical Chemistryskin and connective tissue diseasesInterleukin 6Molecular BiologySpectroscopy030203 arthritis & rheumatologyAutoimmune diseaseKidneySystemic lupus erythematosusbiologyVascular diseasebusiness.industryOrganic ChemistryGeneral MedicineArteriosclerosismedicine.diseaseComputer Science Applications030104 developmental biologymedicine.anatomical_structureImmunologybiology.proteinmedicine.symptombusinessInternational Journal of Molecular Sciences
researchProduct

Gut-derived CD8+ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients

2019

We read with interest the recently published paper from Qaiyum et al 1 demonstrating a novel integrin-expressing mature Crohn's disease (CD)8+ T cell population defined as CD49a+CD103+β7+CD29+ cells in the synovial fluids of ankylosing spondylitis (AS) patients. Although the authors did not analyse gut samples from AS patients, they speculate that these cells might be gut-derived cells. Interestingly, as stated by authors, the transcriptional and phenotypic signature of these cells is reminiscent of human tissue-resident memory T cells (TRM). TRM are a subset of cells important as the first line of defence from infection in mucosal tissues, never studied in spondyloarthritis (SpA).2 For cla…

0301 basic medicineT cellImmunologyPopulationInflammationGeneral Biochemistry Genetics and Molecular BiologyCD49a03 medical and health sciences0302 clinical medicineRheumatologymedicineImmunology and AllergyeducationCytokine030203 arthritis & rheumatologyInflammationAnkylosing spondylitiseducation.field_of_studyAnkylosing Spondylitibusiness.industryCD29medicine.diseasePhenotypeSettore MED/16 - Reumatologia030104 developmental biologymedicine.anatomical_structureImmunologymedicine.symptombusinessCD8
researchProduct

Balanced Bcl-3 expression in murine CD4+T cells is required for generation of encephalitogenic Th17 cells

2017

The function of NF-κB family members is controlled by multiple mechanisms including the transcriptional regulator Bcl-3, an atypical member of the IκB family. By using a murine model of conditional Bcl-3 overexpression specifically in T cells, we observed impairment in the development of Th2, Th1 and Th17 cells. High expression of Bcl-3 promoted CD4+ T-cell survival, but at the same time suppressed proliferation in response to TCR stimulation, resulting in reduced CD4+ T-cell expansion. As a consequence, T cell specific overexpression of Bcl-3 led to reduced inflammation in the small intestine of mice applied with anti-CD3 in a model of gut inflammation. Moreover, impaired Th17-cell develop…

0301 basic medicineT cellMultiple sclerosisImmunologyT-cell receptorStimulationInflammationNF-κBBiologymedicine.diseaseSmall intestineCell biology03 medical and health scienceschemistry.chemical_compound030104 developmental biologymedicine.anatomical_structurechemistryImmunologymedicineTranscriptional regulationImmunology and Allergymedicine.symptomEuropean Journal of Immunology
researchProduct

Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

2019

Almost all multiple myeloma (MM) cases have been demonstrated to be linked to earlier monoclonal gammopathy of undetermined significance (MGUS). Nevertheless, there are no identified characteristics in the diagnosis of MGUS that have been helpful in differentiating subjects whose cancer may progress to a malignant situation. Regarding malignancy, the role of lymphocyte subsets and cytokines at the beginning of neoplastic diseases is now incontestable. In this review, we have concentrated our attention on the equilibrium between the diverse lymphocyte subsets and the cytokine system and summarized the current state of knowledge, providing an overview of the condition of the entire system in …

0301 basic medicineT lymphocytesimmunosurveillanceReviewMalignancyMonoclonal Gammopathy of Undetermined SignificanceCatalysisInorganic Chemistrylcsh:Chemistry03 medical and health sciences0302 clinical medicineImmune systemSettore MED/43 - Medicina LegaleMonitoring ImmunologicGammopathycytokineMedicineHumansPhysical and Theoretical ChemistryMolecular Biologylcsh:QH301-705.5SpectroscopyMultiple myelomamonoclonal gammopathy of undetermined significance; multiple myeloma; T lymphocytes; cytokine; alarmin; inflammation; immunosurveillancebusiness.industryOrganic ChemistryCancerGeneral Medicinealarminmedicine.diseaseLymphocyte SubsetsComputer Science ApplicationsImmunosurveillancemultiple myeloma030104 developmental biologylcsh:Biology (General)lcsh:QD1-999inflammation030220 oncology & carcinogenesisImmunologyMonoclonalCytokinesbusinessMonoclonal gammopathy of undetermined significance
researchProduct

Time to activin on pathogenic T cells

2020

In multiple sclerosis (MS), Th17 cells are critical drivers of autoimmune central nervous system (CNS) inflammation and demyelination. Th17 cells exhibit functional heterogeneity fostering both pathogenic and nonpathogenic, tissue-protective functions. Still, the factors that control Th17 pathogenicity remain incompletely defined. Here, using experimental autoimmune encephalomyelitis, an established mouse MS model, we report that therapeutic administration of activin-A ameliorates disease severity and alleviates CNS immunopathology and demyelination, associated with decreased activation of Th17 cells. In fact, activin-A signaling through activin-like kinase-4 receptor represses pathogenic t…

0301 basic medicineT-Lymphocytesmedicine.medical_treatmentAutoimmune Diseases03 medical and health sciences0302 clinical medicineCerebrospinal fluidImmune systemCommentariesDemyelinating diseaseMedicineCytotoxic T cellNeuroinflammationInflammationMultidisciplinaryVirulencebusiness.industryMultiple sclerosisBiological Sciencesmedicine.diseaseActivins030104 developmental biologyCytokineImmunologybusinessCD8030215 immunologyProceedings of the National Academy of Sciences
researchProduct